NAUT nautilus.bio: Year-over-year earnings per share growth for the last twelve months
The financial stability of Nautilus Biotechnology (NAUT) is constrained by its R&D stage and reliance on external financing. A snapshot of quarterly EPS dynamics visualizes this volatility, where -14.30 shapes the current metric. Growth relies on an AI protein mapping platform with high switching costs for clients, positioned at the start of the global proteomics development cycle, which isolates the asset from macroeconomic trends.
Summary analytical data breakdowns for Nautilus Biotechnology (NAUT)
- share price and consensus valuation forecast:
- company stock capitalization data:
- book capitalization data:
- debt level and financial liquidity data:
Total Debt to Capital Nautilus Biotechnology|NAUT - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity nautilus.bio|NAUT - Company Cumulative Debt|Debt to Book Value Nautilus Biotechnology Inc|NAUT - Amount of Long-Term Liabilities|Company Short-Term Debts Nautilus Biotechnology|Quick Ratio nautilus.bio
- earnings and valuation multiples information:
NAUT - Net Income|Projected Future Earnings Nautilus Biotechnology|NAUT - Company Value to Net Income|Future Price to Earnings nautilus.bio|NAUT - Growth-Adjusted P/E Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nautilus Biotechnology Inc|NAUT - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Nautilus Biotechnology|NAUT - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months nautilus.bio|NAUT - Earnings per share growth rate in current year|Earnings growth forecast for next year Nautilus Biotechnology
- sales revenue and business income indicators:
Comprehensive company analysis:Nautilus Biotechnology, Inc., NAUT
For Nautilus Biotechnology (NAUT), the quarterly EPS growth rate reflects the dynamics of net income per share, highlighting the efficiency of software development against the costs of third-party chip manufacturing. Analysis of this chart allows for an assessment of business scaling rates and the timely identification of a gap between market expectations and actual profitability, which is critical for protecting capital from overvaluation.
Competitor analysis for Nautilus Biotechnology
TEM (Tempus AI Inc) - Year-over-year net earnings per share growth for the last 12 months|Qiagen NV (QGEN) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Ionis Pharma|Repligen Inc. (RGEN) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months RNA (Avidity Biosciences)|CRSP (crisprtx.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth WGS (GeneDx)|Ultragenyx Pharmaceutical Inc. - Year-over-year earnings per share growth for the last twelve months|Beam Therapeutics Corp - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Sarepta Corp SRPT|Twist Bioscience (TWST) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months 10xgenomics.com (TXG)|Year-over-year net earnings per share growth for the last 12 months NTLA|STOK (Stoke Therapeutics Inc) - Year-over-year earnings per share growth rate for the last twelve months|Quarterly EPS earnings growth BLFS|WVE - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth MAZE (Maze Therapeutics Inc)|SION - Year-over-year net earnings per share growth for the last 12 months|Prime Medicine - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months TSHA (Taysha Gene Therapies Inc)|uniQure Corp (QURE) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months MGTX|Year-over-year earnings per share growth for the last twelve months REGENXBIO Inc.|Earnings per share growth in annualized terms for the last twelve months solidbio.com SLDB|Year-over-year earnings per share growth for the last twelve months Ocugen (OCGN)|Year-over-year earnings per share growth for the last twelve months PACB (Pacific Biosciences of California, Inc.)|Year-over-year earnings per share growth for the last twelve months Benitec BNTC|Design Corp (DSGN) - Earnings per share growth in annualized terms for the last twelve months|Rocket Pharmaceuticals - Quarterly EPS earnings growth|Net earnings per share growth for the trailing year 4dmoleculartherapeutics.com (FDMT)|LXEO (lexeotx.com) - Year-over-year net earnings per share growth for the last 12 months|Earnings per share growth in annualized terms for the last twelve months Korro Bio (KRRO)|Year-over-year earnings per share growth for the last twelve months Editas|Year-over-year earnings per share growth for the last 12 months SLN (Silence Therapeutics Corp)|Quarterly EPS earnings growth PRQR|Quarterly EPS earnings growth codexis.com (CDXS)|Sangamo Therapeutics, Inc. - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Metagenomi Inc. MGX|DTIL: Year-over-year net earnings per share growth for the last 12 months|Generation Bio Co. - Year-over-year earnings per share growth rate for the last twelve months|BOLD: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months XCUR|Year-over-year earnings per share growth for the last twelve months Imunon Inc|Year-over-year earnings per share growth for the last 12 months PHIO (RXi Pharmaceuticals)|Quarterly EPS earnings growth MBIO|Quarterly EPS earnings growth transcodetherapeutics.com (RNAZ)|Year-over-year earnings per share growth for the last twelve months Bionano Genomics BNGO|APDN: Year-over-year earnings per share growth for the last 12 months|bluebird bio - Quarterly EPS earnings growth|IPA - Quarterly EPS earnings growth|OMGA (Omega) - Year-over-year net earnings per share growth for the last 12 months|Singular Genomics Corp (OMIC) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months RGLS|SYRS (syros.com) - Year-over-year earnings per share growth rate for the last twelve months|Quarterly EPS earnings growth TBIO|Year-over-year net earnings per share change for the last twelve months TRACON Pharmaceuticals Inc.|Year-over-year earnings per share growth for the last twelve months Unity Bio UBX
